Clinical Trial Update: Protection of the Heart With Doxycycline During Coronary Artery Bypass Grafting [Phase 2]

View source ↗

Summary

Phase 2 trial updating the protection of the heart with doxycycline during coronary artery bypass grafting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemia-reperfusion Injury

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: University of Alberta | Conditions: Coronary Artery Bypass Grafting, Cardiopulmonary Bypass | Phase 2 | Status: COMPLETED | Results posted: 2017-12-15